abstract |
The present invention provides piperidin-4-ylazetidine derivatives, as well as compositions and methods of use thereof, which modulate the activity of Janus kinase 1 (JAK1) and are useful in the treatment of diseases associated with the activity of JAK1, including, for example Inflammatory disorders, autoimmune disorders, cancer and other diseases. |